Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $3.60 billion. The enterprise value is $2.87 billion.
| Market Cap | 3.60B |
| Enterprise Value | 2.87B |
Important Dates
The next confirmed earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 122.12 million shares outstanding. The number of shares has increased by 1.85% in one year.
| Current Share Class | 122.12M |
| Shares Outstanding | 122.12M |
| Shares Change (YoY) | +1.85% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 87.41% |
| Float | 114.53M |
Valuation Ratios
The trailing PE ratio is 17.52 and the forward PE ratio is 15.66. CPRX's PEG ratio is 1.33.
| PE Ratio | 17.52 |
| Forward PE | 15.66 |
| PS Ratio | 6.07 |
| Forward PS | 5.56 |
| PB Ratio | 3.76 |
| P/TBV Ratio | 4.34 |
| P/FCF Ratio | 17.13 |
| P/OCF Ratio | 17.12 |
| PEG Ratio | 1.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.70, with an EV/FCF ratio of 13.74.
| EV / Earnings | 13.38 |
| EV / Sales | 4.87 |
| EV / EBITDA | 9.70 |
| EV / EBIT | 11.12 |
| EV / FCF | 13.74 |
Financial Position
The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.08 |
| Quick Ratio | 5.69 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.49% and return on invested capital (ROIC) is 81.01%.
| Return on Equity (ROE) | 25.49% |
| Return on Assets (ROA) | 16.48% |
| Return on Invested Capital (ROIC) | 81.01% |
| Return on Capital Employed (ROCE) | 26.94% |
| Weighted Average Cost of Capital (WACC) | 7.90% |
| Revenue Per Employee | $3.24M |
| Profits Per Employee | $1.18M |
| Employee Count | 182 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 3.53 |
Taxes
In the past 12 months, CPRX has paid $69.19 million in taxes.
| Income Tax | 69.19M |
| Effective Tax Rate | 24.40% |
Stock Price Statistics
The stock price has increased by +25.54% in the last 52 weeks. The beta is 0.66, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +25.54% |
| 50-Day Moving Average | 24.75 |
| 200-Day Moving Average | 22.60 |
| Relative Strength Index (RSI) | 75.22 |
| Average Volume (20 Days) | 1,848,693 |
Short Selling Information
The latest short interest is 8.49 million, so 6.95% of the outstanding shares have been sold short.
| Short Interest | 8.49M |
| Short Previous Month | 9.13M |
| Short % of Shares Out | 6.95% |
| Short % of Float | 7.42% |
| Short Ratio (days to cover) | 7.17 |
Income Statement
In the last 12 months, CPRX had revenue of $588.99 million and earned $214.33 million in profits. Earnings per share was $1.68.
| Revenue | 588.99M |
| Gross Profit | 489.03M |
| Operating Income | 257.78M |
| Pretax Income | 283.52M |
| Net Income | 214.33M |
| EBITDA | 295.65M |
| EBIT | 257.78M |
| Earnings Per Share (EPS) | $1.68 |
Balance Sheet
The company has $709.17 million in cash and $2.79 million in debt, giving a net cash position of $706.38 million or $5.78 per share.
| Cash & Cash Equivalents | 709.17M |
| Total Debt | 2.79M |
| Net Cash | 706.38M |
| Net Cash Per Share | $5.78 |
| Equity (Book Value) | 954.27M |
| Book Value Per Share | 7.79 |
| Working Capital | 746.88M |
Cash Flow
In the last 12 months, operating cash flow was $208.67 million and capital expenditures -$58,000, giving a free cash flow of $208.61 million.
| Operating Cash Flow | 208.67M |
| Capital Expenditures | -58,000 |
| Depreciation & Amortization | 37.87M |
| Net Borrowing | n/a |
| Free Cash Flow | 208.61M |
| FCF Per Share | $1.71 |
Margins
Gross margin is 83.03%, with operating and profit margins of 43.77% and 36.39%.
| Gross Margin | 83.03% |
| Operating Margin | 43.77% |
| Pretax Margin | 48.14% |
| Profit Margin | 36.39% |
| EBITDA Margin | 50.20% |
| EBIT Margin | 43.77% |
| FCF Margin | 35.42% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.85% |
| Shareholder Yield | -1.85% |
| Earnings Yield | 6.00% |
| FCF Yield | 5.84% |
Analyst Forecast
The average price target for CPRX is $35.00, which is 18.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.00 |
| Price Target Difference | 18.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 6.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 13.56 and a Piotroski F-Score of 4.
| Altman Z-Score | 13.56 |
| Piotroski F-Score | 4 |